Cutler Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Cutler Group’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,200	Closed	-$13K	–	8097
2016 Q3	$13K	Buy	29,200 +17,800	+156%	+$127K	﹤0.01%	3958
2016 Q2	$40K	Buy	11,400 +900	+9%	+$4.61K	﹤0.01%	2604
2016 Q1	$46K	Sell	10,500 -70,600	-87%	-$284K	﹤0.01%	2438
2015 Q4	$249K	Buy	+81,100	New	+$471K	0.01%	1014

Cutler Group's RPTP Position: Q4 2016 in Review

Cutler Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 6,126 shares — an estimated $54K sold.

Cutler Group first reported a position in RPTP in Q4 2015 and held it in 4 quarters. The position peaked at $296K in Q4 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Cutler Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Cutler Group sold 6,126 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $54K.
Cutler Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2015 and held it in 4 quarters.
Cutler Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $296K in Q4 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Cutler Group's 13F filing for Q4 2016, filed 12 Jan 2017.